Drug intelligence / Profile preview

PREPROTO-M

Development stage: Unknown
Lead developer: RANTOMO Life Sciences Bharat
Modality: Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
Administration: Oral

Overview

PREPROTO-M is an oral nutraceutical product developed and marketed by Rantomo Lifesciences, a pharmaceutical company based in Mumbai, India. It is formulated as a prebiotic and probiotic supplement designed to support digestive and gut health. While the specific microbial strains and prebiotic components are not explicitly detailed in the company's primary literature, the product name follows a common industry convention for 'Pre-Pro' (prebiotic and probiotic) combinations. Such formulations typically contain a blend of beneficial bacteria, such as *Lactobacillus* and *Bifidobacterium* species, alongside prebiotic fibers like fructooligosaccharides (FOS) to restore and maintain a healthy intestinal microbiome. It is marketed as a commercial product for general gut health maintenance and as a supportive therapy for gastrointestinal disturbances.

Brand names: PREPROTO-M

Beyond the preview

Go deeper on PREPROTO-M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PREPROTO-M.

Explore the full profile